The global mobile ECG devices market size is anticipated to reach USD 5.42 billion by 2030, based on a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 11.7% from 2023 to 2030. The widespread adoption of mobile ECG devices can be largely attributed to the increasing global elderly population. According to the World Health Organization (WHO), October 2022 highlights the remarkable transformation of the demographic landscape. It is projected that by 2030, one in every six individuals worldwide will have reached the age of 60 or greater. This demographic shift represents a substantial surge compared to the one billion individuals in this age group recorded in 2020. Looking further ahead to 2050, the global population aged 60 years and above is expected to double, reaching an impressive 2.1 billion individuals. This demographic trend highlights the growing need for healthcare technologies like mobile ECG devices, which are crucial for the health of the elderly population.
A significant milestone in this field is the recent approval by the FDA of a single-lead ECG smartwatch, highlighting its effectiveness in detecting atrial fibrillation (AF) among the general population. This breakthrough emphasizes the potential of smartwatches to serve as robust tools for continuous AF monitoring. Beyond smartwatches, the market has introduced various innovative devices engineered for AF monitoring and detection. According to the NCBI article published in May 2023, a single-lead wireless ECG patch has been designed for comfortable placement on the chest. This patch offers real-time ECG monitoring capabilities and leverages cloud-based data analysis, facilitating seamless data sharing with healthcare professionals.
The mobile ECG (Electrocardiogram) devices market has experienced significant recent growth driven by advancements in technology and a heightened focus on heart health. Mobile ECG devices are influential in cost reduction, enabling remote monitoring and streamlining healthcare processes, ultimately enhancing overall healthcare efficiency. These devices have also attracted substantial investments, fostering international trade and driving innovation in related industries. In essence, the market catalyzes economic growth, champions heart health, and addresses the economic challenges associated with cardiovascular diseases.
Request a free sample copy or view report summary: Mobile ECG Devices Market Report
Based on region, North America held the largest revenue share of 48.5% in the market. The significant growth of this region's market is driven by several factors, including the substantial geriatric population, advanced healthcare infrastructure, and relatively high disposable incomes
In terms of modality, the handheld category dominated the market in 2022 primarily with a revenue share of 41.2% due to its balanced combination of portability and functionality
In terms of end-use, the hospitals and diagnostic centers segment dominated the market in 2022 with a revenue share of 48.7%. This is primarily attributed to the significant patient population served by hospitals, particularly in emerging and low-income nations, which is driving the demand for mobile ECG devices
Grand View Research has segmented the global mobile ECG devices market based on modality, end-use, and region:
Mobile ECG Devices Modality Outlook (Revenue, USD Billion, 2018 - 2030)
Pen
Band
Handheld
Others
Mobile ECG Devices End-use Outlook (Revenue, USD Billion, 2018 - 2030)
Hospitals And Diagnostic Centers
Ambulatory Care
Homecare
Mobile ECG Devices Regional Outlook (Revenue, USD Billion, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Asia Pacific
China
Japan
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East And Africa
Saudi Arabia
South Africa
UAE
Kuwait
List of Key Players in the Mobile ECG Devices Market
New York Plastic Surgical Group
Nihon Kohden Corporation
GE Healthcare
Medtronic
iRhythm Technologies, Inc.
Koninklijke Philips N.V.
Emay
Dr Trust
Omron
"The quality of research they have done for us has been excellent..."